Contamination Concerns Lead to FDA Warning Against Use of PharmaTech Liquid Products

Screen shot of FDA recall

Screen shot of FDA recall

Through recent communication with FDA, Rugby Laboratories learned of a potential issue with a product manufactured by PharmaTech.

Investigators also detected B. cepacia in the water system used to manufacture the product. "Patients who are using liquid drug products and who have concerns should contact their healthcare professional".

However, determining which products were manufactured by PharmaTech could prove hard "because these liquid products are not labeled with a PharmaTech label", the safety alert states.

At the time, the FDA advised healthcare professionals and patients not to use liquid docusate products made at PharmaTech's Davie, Florida, facility.

The FDA reported several reports of B. cepacia infections in patients involving PharmaTech's Diocto Syrup and Diocto Liquid.

Many consumers will have trouble identifying PharmaTech products because they don't display the company's label.

"This is frustrating because there is virtually no way to purchase a medication based on quality". A major concern is that infection by Burkholderia cepacia may be hard to treat, as the bacteria shows resistance to several antibiotics, the CDC warned.

Last year, PharmaTech recalled all of its liquid products manufactured between October 2015 and July 2016 after the Burkholderia cepacia outbreak.